METLIFE INC
A diversified global financial services powerhouse offering life insurance, annuities, and health solutions with a robust balance sheet.
A diversified global financial services powerhouse offering life insurance, annuities, and health solutions with a robust balance sheet.
Investors may favor MET due to its potential for margin expansion as interest rates stabilize and investment income normalizes following recent market volatility. The company's strong capital return program, evidenced by $4.39B in total shareholder returns last year, demonstrates management's commitment to rewarding investors while deleveraging the balance sheet. Diversified revenue streams across insurance, retirement, and health sectors provide downside protection against sector-specific headwinds.
The massive accumulated other comprehensive income loss of $18.08B indicates significant volatility in unrealized investment gains that could pressure future earnings if market corrections occur. High operating expenses relative to revenue and a substantial retained earnings deficit suggest ongoing structural cost pressures or legacy underwriting challenges. Significant cash outflows from investing activities of $15.61B raise concerns about capital allocation efficiency and potential strain on liquidity reserves.
METLIFE INC (NYSE: MET) is a global leader in life insurance, retirement solutions, and health services, serving customers across North America and India. The company leverages its extensive distribution network to offer comprehensive protection and wealth management products. With total assets exceeding $745 billion, MetLife provides stability and growth through diverse investment portfolios.
In 2025, MetLife reported revenue of $77.08B and net profit of $3.40B, reflecting a strategic recovery following lower profitability in previous years. While operating expenses remained high at $70.95B due to marketing investments of $6.79B, the company successfully generated positive cash flow from operations of $17.09B despite significant investing outflows. The balance sheet remains robust with $22.03B in cash and equivalents, allowing for continued share repurchases of $2.88B and dividend payments of $1.51B.
The global insurance industry is currently navigating a complex environment characterized by low-to-moderate interest rates, inflationary pressures on claims costs, and evolving regulatory landscapes. Companies with strong balance sheets and diversified product mixes like MetLife are better positioned to capture value from rising yields while managing longevity risk. Digital transformation and AI-driven underwriting are becoming essential for maintaining competitiveness in a crowded market.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $69.90B | $66.91B | $70.99B | $77.08B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $69.90B | $66.91B | $70.99B | $77.08B |
| Operating Expenses | $67.04B | $64.74B | $64.99B | $70.95B |
| Operating Income | $2.86B | $2.16B | $6.00B | $6.14B |
| G&A | $700.0M | $828.0M | $481.0M | $560.0M |
| Marketing | $5.26B | $5.82B | $6.02B | $6.79B |
| Stock-Based Comp | $184.0M | $171.0M | $168.0M | $131.0M |
| Depreciation | $171.0M | $112.0M | $124.0M | $117.0M |
| Amortization | $92.0M | $88.0M | $85.0M | $83.0M |
| Other OpEx | $61.07B | $58.10B | $58.49B | $63.60B |
| Non-Operating Income | $0 | $0 | $-374.0M | $-1.48B |
| Pre-Tax Income | $2.86B | $2.16B | $5.62B | $4.66B |
| Income Tax | $301.0M | $560.0M | $1.18B | $1.26B |
| Continuing Ops | $2.56B | $1.60B | $4.44B | $3.40B |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $2.56B | $1.60B | $4.44B | $3.40B |
| Minority Interest | $19.0M | $24.0M | $18.0M | $24.0M |
| Net to Common | $2.54B | $1.58B | $4.43B | $3.38B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $20.20B | $20.64B | $20.07B | $22.03B |
| Marketable Securities | $4.93B | $6.04B | $5.16B | $3.60B |
| Goodwill | $9.30B | $9.24B | $8.90B | $9.61B |
| Operating Leases | $961.0M | $1.06B | $928.0M | $984.0M |
| Total Assets | $666.61B | $687.58B | $677.46B | $745.17B |
| Total Liabilities | $639.32B | $657.33B | $649.75B | $716.25B |
| Shareholders' Equity | $27.29B | $30.25B | $27.70B | $28.92B |
| Paid-In Capital | $33.62B | $33.69B | $33.79B | $32.86B |
| Retained Earnings | $41.95B | $40.15B | $42.63B | $44.29B |
| AOCI | $-27.08B | $-19.24B | $-21.19B | $-18.08B |
| Treasury Stock | $21.46B | $24.59B | $27.80B | $30.68B |
| Total L&E | $666.61B | $687.58B | $677.46B | $745.17B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $2.56B | $1.60B | $4.44B | $3.40B |
| Non-Cash Adjustments | $7.87B | $3.08B | $6.27B | $2.20B |
| Working Capital Changes | $2.78B | $9.04B | $3.88B | $11.48B |
| Cash from Operations | $13.20B | $13.72B | $14.60B | $17.09B |
| Cash from Investing | $-2.62B | $-10.25B | $-11.49B | $-15.61B |
| Debt Issuances | $1.01B | $1.99B | $1.57B | $743.0M |
| Share Buybacks | $3.33B | $3.10B | $3.21B | $2.88B |
| Dividends Paid | $1.60B | $1.57B | $1.53B | $1.51B |
| Cash from Financing | $-10.11B | $-2.94B | $-3.13B | $163.0M |
| FX Effect | $-397.0M | $-91.0M | $-545.0M | $316.0M |
| Net Change in Cash | $79.0M | $444.0M | $-571.0M | $1.96B |
| Beginning Cash | $20.05B | $20.20B | $20.64B | $20.07B |
| Ending Cash | $20.20B | $20.64B | $20.07B | $22.03B |
The company generates revenue primarily through Life Insurance (protection and savings), Retirement Products (annuities and pensions), Health Services (managed care and pharmacy benefits), and Asset Management services which support its core underwriting operations.
Interest rate sensitivity and duration mismatch risks inherent to the insurance business model could impact investment income if market yields shift unexpectedly. Regulatory changes in key markets like India and the US could affect underwriting margins or reserve requirements. Economic downturns may lead to increased claims frequency, higher lapse rates on annuity products, and reduced demand for life insurance policies. Currency exchange fluctuations and geopolitical instability in international operations pose additional volatility risks to earnings.
MetLife possesses one of the world's largest and most diversified distribution networks, combining direct sales with independent agency channels to reach a broad customer base. Its strong investment portfolio, comprising over $745 billion in assets, provides significant float for underwriting growth while generating substantial operating profits. The company benefits from a multi-generational brand reputation and deep expertise in risk management across global markets.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.